Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David W Dowdy

Showing results (31-40 of 288) with videos related to

Pageof 29
Sort By:
American Journal of Epidemiology|February 12, 2016
Ancient Disease, Modern Epidemiology: A Century of Progress in Understanding and Fighting TuberculosisAlice Zwerling, Colleen Hanrahan, David W Dowdy
Plos Medicine|August 23, 2011
Serological testing versus other strategies for diagnosis of active tuberculosis in India: a cost-effectiveness analysisDavid W Dowdy, Karen R Steingart, Madhukar Pai
American Journal of Respiratory and Critical Care Medicine|November 16, 2020
The Epidemiological Importance of Subclinical Tuberculosis. A Critical ReappraisalEmily A Kendall, Sourya Shrestha, David W Dowdy
Plos One|January 10, 2014
Do we need to detect isoniazid resistance in addition to rifampicin resistance in diagnostic tests for tuberculosis?Claudia M Denkinger, Madhukar Pai, David W Dowdy
Plos One|April 29, 2015
Costs and Consequences of Using Interferon-γ Release Assays for the Diagnosis of Active Tuberculosis in IndiaKristen M Little, Madhukar Pai, David W Dowdy
American Journal of Respiratory and Critical Care Medicine|March 10, 2021
Reply to Pierce: Subclinical Tuberculosis: Some Flies in the OintmentEmily A Kendall, Sourya Shrestha, David W Dowdy
American Journal of Respiratory and Critical Care Medicine|December 25, 2012
Is passive diagnosis enough? The impact of subclinical disease on diagnostic strategies for tuberculosisDavid W Dowdy, Sanjay Basu, Jason R Andrews
Journal of the International AIDS Society|June 21, 2020
Towards evidence-based integration of services for HIV, non-communicable diseases and substance use: insights from modellingDavid W Dowdy, Kimberly A Powers, Timothy B Hallett
Proceedings of the National Academy of Sciences of the United States of America|December 19, 2022
Infectious and clinical tuberculosis trajectories: Bayesian modeling with case finding implicationsTheresa S Ryckman, David W Dowdy, Emily A Kendall
The Lancet. Respiratory Medicine|December 20, 2016
Expected effects of adopting a 9 month regimen for multidrug-resistant tuberculosis: a population modelling analysisEmily A Kendall, Anthony T Fojo, David W Dowdy
Pageof 29

Showing results (31-40 of 288) with videos related to

Sort By:
Pageof 29
American Journal of Epidemiology|February 12, 2016
Ancient Disease, Modern Epidemiology: A Century of Progress in Understanding and Fighting TuberculosisAlice Zwerling, Colleen Hanrahan, David W Dowdy
Plos Medicine|August 23, 2011
Serological testing versus other strategies for diagnosis of active tuberculosis in India: a cost-effectiveness analysisDavid W Dowdy, Karen R Steingart, Madhukar Pai
American Journal of Respiratory and Critical Care Medicine|November 16, 2020
The Epidemiological Importance of Subclinical Tuberculosis. A Critical ReappraisalEmily A Kendall, Sourya Shrestha, David W Dowdy
Plos One|January 10, 2014
Do we need to detect isoniazid resistance in addition to rifampicin resistance in diagnostic tests for tuberculosis?Claudia M Denkinger, Madhukar Pai, David W Dowdy
Plos One|April 29, 2015
Costs and Consequences of Using Interferon-γ Release Assays for the Diagnosis of Active Tuberculosis in IndiaKristen M Little, Madhukar Pai, David W Dowdy
American Journal of Respiratory and Critical Care Medicine|March 10, 2021
Reply to Pierce: Subclinical Tuberculosis: Some Flies in the OintmentEmily A Kendall, Sourya Shrestha, David W Dowdy
American Journal of Respiratory and Critical Care Medicine|December 25, 2012
Is passive diagnosis enough? The impact of subclinical disease on diagnostic strategies for tuberculosisDavid W Dowdy, Sanjay Basu, Jason R Andrews
Journal of the International AIDS Society|June 21, 2020
Towards evidence-based integration of services for HIV, non-communicable diseases and substance use: insights from modellingDavid W Dowdy, Kimberly A Powers, Timothy B Hallett
Proceedings of the National Academy of Sciences of the United States of America|December 19, 2022
Infectious and clinical tuberculosis trajectories: Bayesian modeling with case finding implicationsTheresa S Ryckman, David W Dowdy, Emily A Kendall
The Lancet. Respiratory Medicine|December 20, 2016
Expected effects of adopting a 9 month regimen for multidrug-resistant tuberculosis: a population modelling analysisEmily A Kendall, Anthony T Fojo, David W Dowdy
Pageof 29